Correlation Between SIMON and Design Therapeutics

Can any of the company-specific risk be diversified away by investing in both SIMON and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SIMON and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SIMON PPTY GROUP and Design Therapeutics, you can compare the effects of market volatilities on SIMON and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SIMON with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SIMON and Design Therapeutics.

Diversification Opportunities for SIMON and Design Therapeutics

0.36

Correlation Coefficient

SIMON  Design Therapeutics

Weak diversification

The 3 months correlation between SIMON and Design is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding SIMON PPTY GROUP and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and SIMON is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SIMON PPTY GROUP are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of SIMON i.e., SIMON and Design Therapeutics go up and down completely randomly.

Pair Corralation between SIMON and Design Therapeutics

Assuming the 90 days trading horizon SIMON is expected to generate 7.62 times less return on investment than Design Therapeutics. But when comparing it to its historical volatility, SIMON PPTY GROUP is 3.7 times less risky than Design Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Design Therapeutics is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  353.00  in Design Therapeutics on May 19, 2025 and sell it today you would earn a total of  180.00  from holding Design Therapeutics or generate 50.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	52.38%
Values	Daily Returns

SIMON PPTY GROUP  vs.  Design Therapeutics

SIMON PPTY GROUP

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in SIMON PPTY GROUP are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, SIMON is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Design Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Design Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SIMON and Design Therapeutics

The main advantage of trading using opposite SIMON and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SIMON position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.

The idea behind SIMON PPTY GROUP and Design Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.